[1]
Kääriäinen, O.-S. et al. 2025. Real-world outcomes of 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: the KuPSMALu trial in Eastern Finland. Acta Oncologica. 64, (Nov. 2025), 1515–1522. DOI:https://doi.org/10.2340/1651-226X.2025.44748.